Sunday, November 24, 2024 4:57:17 PM
I think most of the so-called bashers are people who want to see Anavex succeed for the benefit of patients and shareholders but are frustrated by the incompetence demonstrated by our CEO and the complacency of the directors and would like to see a change for the better.
You seem to have a problem with having a reasonable debate. For you it’s Anavex, love it or leave it. That’s sad in my opinion.
Recent AVXL News
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 12/12/2025 09:05:00 PM
- Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference • GlobeNewswire Inc. • 11/26/2025 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/25/2025 09:31:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 12:30:48 PM
- Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/25/2025 12:30:00 PM
- Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference • GlobeNewswire Inc. • 11/19/2025 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 • GlobeNewswire Inc. • 11/18/2025 12:30:00 PM
- Anavex shares collapse after CHMP issues negative signal on Alzheimer’s therapy • IH Market News • 11/14/2025 01:45:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 12:42:01 PM
- Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease • GlobeNewswire Inc. • 11/14/2025 12:30:00 PM
- Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group • GlobeNewswire Inc. • 10/29/2025 11:30:00 AM
- Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’ • GlobeNewswire Inc. • 10/10/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2025 12:42:50 AM
- Anavex shares climb on upbeat results from schizophrenia trial • IH Market News • 10/02/2025 12:45:17 PM
- Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program • GlobeNewswire Inc. • 10/02/2025 11:35:00 AM
- Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia • GlobeNewswire Inc. • 10/02/2025 11:30:00 AM
- Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial • GlobeNewswire Inc. • 09/09/2025 11:30:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025 • GlobeNewswire Inc. • 09/02/2025 11:30:00 AM
- Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine • GlobeNewswire Inc. • 08/26/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2025 09:30:21 PM
- Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease • GlobeNewswire Inc. • 08/20/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2025 08:08:20 PM
- Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/12/2025 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025 • GlobeNewswire Inc. • 08/05/2025 11:30:00 AM
One World Products (to become Isiah Enterprises) Targets December Operational Breakeven; 250,000+ Pounds of Pelletized Rubber Shipped • OWPC • Dec 10, 2025 11:24 AM
Growing Momentum Signals Opportunity as Explorers Shift Toward Production, Reveal Substantial Value • LFLRF • Dec 10, 2025 9:00 AM
Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • BLEG • Dec 10, 2025 9:00 AM
Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing • BLO • Dec 9, 2025 8:45 AM
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival • AVAI • Dec 9, 2025 8:00 AM
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value • B • Dec 8, 2025 9:00 AM
